Klisura Dean Michael, the President and CEO of Marsh RE, recently sold 4,194 shares of common stock in Marsh & McLennan Companies, Inc. This sale took place on October 23, 2026, at a price of $200 per share. The transaction is significant as it reflects ongoing financial management strategies within the company.
Marsh & McLennan is a prominent player in the insurance industry, specifically categorized under insurance agents, brokers, and services. The company, which trades under the ticker MRSH, has a long-standing reputation in providing risk management and insurance solutions.
The filing indicates that Michael's sale was executed as part of a Rule 10b5-1 trading plan, a strategy often utilized by executives to manage their stock transactions in a transparent manner. Following this transaction, Michael retains ownership of approximately 20,935.48 shares of the company.
This development may impact stakeholders, including investors and employees, as it underscores the importance of executive stock transactions in maintaining corporate governance and transparency. Such moves can affect market perceptions and influence other executives' decisions within the industry.
Details were not available in the SEC filing regarding any future actions or implications stemming from this transaction.
Additional Details on the Transaction
The SEC filing specifies that Klisura Dean Michael's transaction was executed under a Rule 10b5-1 trading plan, which allows for pre-arranged stock sales to avoid any appearance of insider trading. This plan was previously adopted by Michael, indicating a structured approach to managing his equity holdings.
Following the sale of 4,194 shares, Michael's total ownership in Marsh & McLennan Companies, Inc. stands at approximately 20,935.48 shares. This reflects a significant level of continued investment in the company, suggesting confidence in its future performance.
Company Background
Marsh & McLennan Companies, Inc. is incorporated in Delaware and operates under the Standard Industrial Classification of insurance agents, brokers, and services. The company has a fiscal year that ends on December 31st, and its business address is also listed as 1166 Avenue of the Americas, New York, NY 10036.
“This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.”
Details regarding the specific reasons for this transaction or any future plans related to Michael's holdings were not disclosed in the filing.